26 June 2024 - AGM update
The company has issued a positive trading update with successful trials of AVA6000 being recorded. The company has also strengthened the Board with new appointments and the formation of a Scientific Advisory Board is a further positive step. The financial performance of the year to date is in line with expectations and the group had cash for some £35m at the end of May. The shares are a BUY
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
